Blueshift Asset Management’s AstraZeneca AZN Stock Holding History

Blueshift Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,942	Closed	-$298K	–	474
2025 Q3	$298K	Buy	1,942 +94	+5%	+$14.2K	0.09%	306
2025 Q2	$258K	Buy	+1,848	New	+$259K	0.08%	322
2025 Q1	–	Sell	-2,178	Closed	-$285K	–	399
2024 Q4	$285K	Buy	2,178 +456	+26%	+$63.8K	0.1%	264
2024 Q3	$268K	Buy	+1,722	New	+$278K	0.07%	296
2024 Q1	–	Sell	-2,000	Closed	-$269K	–	276
2023 Q4	$269K	Buy	+2,000	New	+$260K	0.14%	199
2023 Q3	–	Sell	-2,446	Closed	-$350K	–	284
2023 Q2	$350K	Buy	+2,446	New	+$360K	0.13%	189
2022 Q3	–	Sell	-2,974	Closed	-$393K	–	601
2022 Q2	$393K	Buy	+2,974	New	+$390K	0.06%	377
2022 Q1	–	Sell	-4,020	Closed	-$468K	–	829
2021 Q4	$468K	Sell	4,020 -6,117	-60%	-$720K	0.04%	496
2021 Q3	$1.22M	Buy	10,137 +5,969	+143%	+$695K	0.07%	358
2021 Q2	$499K	Buy	+4,168	New	+$457K	0.03%	564
2020 Q1	–	Sell	-7,448	Closed	-$743K	–	214
2019 Q4	$743K	Buy	+7,448	New	+$701K	0.08%	340
2019 Q1	–	Sell	-8,919	Closed	-$677K	–	703
2018 Q4	$677K	Buy	+8,919	New	+$696K	0.13%	269

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Blueshift Asset Management's AZN Position: Q4 2025 in Review

Blueshift Asset Management sold out of AstraZeneca (AZN) in Q4 2025, closing a stake of 1,942 shares — an estimated $298K sold.

Blueshift Asset Management first reported a position in AZN in Q4 2018 and held it in 12 quarters. The position peaked at $1.22M in Q3 2021. 1,406 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

Blueshift Asset Management reported no remaining AstraZeneca position as of Q4 2025 after selling out during the quarter.
Blueshift Asset Management sold 1,942 AstraZeneca shares in Q4 2025, an estimated $298K.
Blueshift Asset Management first reported a position in AstraZeneca in Q4 2018 and held it in 12 quarters.
Blueshift Asset Management's AstraZeneca position peaked at $1.22M in Q3 2021.
1,406 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on Blueshift Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.